B.N.Rathi Securities Ltd.

IPO

IPO Snapshot

Syncom Healthcare Ltd.

Issue Open Date	27-Jan-10
Issue Closing Date	29-Jan-10
Application Money	100
Allotment Money

Price Band ()	65 - 75
Minimum Bid Quantity.	90
Issue Size (Shares)	7500000
Market Lot	1

Objective

The objects of the Issue are set forth below:1. To set up our new manufacturing unit at Indore SEZ for manufacturing of various pharmaceuticalsformulations2. To undertake the upgradation/modernization of manufacturing facilities at Dehradun Plant3. To Meet Working Capital Requirements4. To set up an Export Office at Mumbai5. To undertake â€œBrand & Product Registration and Approvalâ€6. To meet General Corporate Purpose: and7. To meet Issue Expenses

Business Description

Syncom Healthcare Limited (SHL) was incorporated on July 29, 2002 by Mr. Ajay Bankda & Mrs. JyotiBankda for manufacturing, marketing & trading of pharmaceuticals formulations under its own brands inEthical, OTC, Generic and Herbal market segment. The registered office of the company is situated at 221,Vyapar Bhawan, P.Dâ€™Mello Road, Mumbai-400009.In its first year of the operation itself i.e....

Promoter's Holding

Total Share Capital	10000000
Offered to Public	7500000
Promoter's Holding (Pre-Issue)	100
Promoter's Holding (Post-Issue)	57.14

Address

Address :Shop No. F-44
1st Floor Shagun Arcade
Co-operative Society Ltd.
A K Vaidya Marg

Opp. Hdfc Bank
Malad East City :Mumbai, State :Maharashtra Pincode :400097 Phone : Email : shl@syncomhealthcare.com Website : www.syncomhealthcare.com

Registrar

Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai

Listed at

BSE, NSE

Lead Manager

Chartered Capital & Investment Ltd

Promoters

Ajay Bankda
Jyoti Bankda

Investor Alert

1) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. 2) For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors. 3) For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors. 4) No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. 5) Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. 6) This is to inform that we B N Rathi securities Ltd not required to have a Business Continuity/DR plan under the existing regulatory provisions.

ATTENTION INVESTORS | KYC | IPO

Prevent Unauthorised transactions in your Trading/Demat Account. Update your mobile numbers/email IDs with your stock brokers/DP. Receive information of your transactions directly from Exchanges/Depositories on your mobile/email at the end of the day. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account......Issued in the interest of investors. SEBI Circular - Investor Grievance Redress Mechanism - New Policy Measures. Kindly refer at Policies.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account

REGISTRATION NOS: SEBI Registration No: INZ000160834 (BSE-3233 | NSE-07141| MCX-56475) CDSL : SEBI Regn No. IN-DP-612-2021. AMFI-Registered Mutual Fund Distributor: B.N.Rathi Securities Ltd - ARN-77516: (B.N.Rathi is just acting as distributor. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.) CIN: L65993TG1985PLC005838

GRIEVANCE CONTACT Investor Grievance Contact: investorgrievances@bnrsecurities.com | DP Investor Grievance: investorgrievances@bnrsecurities.com Investor Protection and Arbitration Exchange Circulars and Rules - NSE,BSE and MCX.

In case of member having a website, member has created awareness amongst clients / investors with regard to procedure of pledge/ re-pledge of securities and displayed the guidelines on the homepage of their respective websites at a prominent place as required in Exchange circular ref no. NSE/INSP/45565 dated Sep 02,2020 Trading members had displayed the set of standard documents/policies on their own website for information.

SEBI SCORES LETTER OF AUTHORITY BROKERS NORMS RMS POLICY PMLA-POLICY SURVEILLANCE POLICY KYC MANDATORY - 6 ATTRIBUTES EVoting CDSL EVoting NSDL

DISCLAIMER INACTIVE CLIENT POLICY PRIVACY POLICY TERMS & CONDITIONS COMPANY POLICIES INVESTOR GRIEVANCE REDRESSAL POLICY INVESTOR CHARTER INVESTOR CHARTER - DP INVESTOR CHARTER - RESEARCH ANALYST INVESTOR CHARTER IGC MIS ADVISORY FOR INVESTORS BNRSL-DISCLAIMERS RESEARCH REPORTS